SEC CIK 1791477

Calderon Nancy E.

Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
NTICview stock →20,939.5442026-09-01
BDCview stock →9,8662026-05-21

Position History — NTIC

Reported shares owned immediately after each Form 4 transaction, over time.

06,98013,96020,9402020-072022-112023-112024-082025-022025-092026-09

Recent Filings — NTIC

DateActivitySharesPriceOwned After
2026-09-01Grant / award6,188$0.0020,939.544
2026-02-11L2.533$8.6614,751.544
2026-02-11L2.365$8.6614,749.011
2025-11-12L2.698$8.1214,746.646
2025-11-12L2.521$8.1214,743.948
2025-09-01Grant / award6,739$0.0014,741.427
2025-08-13L2.834$7.728,002.427
2025-08-13L2.648$7.727,999.593
2025-05-14L2.973$7.357,996.945
2025-05-14L2.777$7.357,993.972
2025-04-25Open-market buy1,000$7.457,954.464
2025-02-12L13.5$11.267,991.195
2025-02-12L6.433$11.267,977.696
2024-11-13L11.377$13.297,971.262
2024-11-13L5.422$13.297,959.885
2024-09-01Grant / award3,771$0.006,954.464
2024-08-14L11.273$13.343,183.464
2024-08-14L5.974$11.993,172.19
2024-05-15L12.663$11.833,166.216
2024-05-15L3.956$18.043,153.553
2024-02-14L11.06$13.473,149.597
2024-02-14L5.208$13.633,138.536
2023-11-16L11.18$13.253,133.328
2023-11-16L5.877$12.013,122.148
2023-09-01Grant / award (derivative)9,921$0.009,921
2023-08-17L13.982$13.073,116.271
2023-08-14Open-market buy500$13.173,061.69
2023-05-18L15.706$11.563,102.289
2023-02-21L13.718$13.173,086.583
2023-01-30Open-market buy500$12.922,561.69
2022-11-16L11.18$12.963,072.865
2022-09-01Grant / award (derivative)10,309$0.0010,309
2022-08-18L12.63$11.392,061.69
2022-05-19L14.27$10.022,049.05
2022-02-17L10.68$13.322,034.78
2021-11-18L8.64$16.392,024.1
2021-09-01Grant / award (derivative)6,859$0.006,859
2021-01-25Open-market buy1,000$14.782,000
2020-09-01Grant / award (derivative)16,026$0.0016,026
2020-07-23Open-market buy1,000$8.601,000
2019-10-22Grant / award (derivative)8,366$0.008,366

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.